We are live on ! Find out more
AP

Andera Partners Portfolio holdings

AUM $177M
This Fund
S&P 500
This Quarter Est. Return
-7.93%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$177M
AUM Growth
+$309K
Cap. Flow
+$27.7M
Cap. Flow %
15.63%
Top 10 Hldgs %
100%
Holding
7
New
2
Increased
1
Reduced
Closed

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KMTS
1
Kestra Medical Technologies
KMTS
$1.43B
$53.7M 30.36%
2,695,192
+155,086
+6% +$3.66M
EVMN
2
Evommune Inc
EVMN
$437M
$43.6M 24.66%
1,897,362
MLYS icon
3
Mineralys Therapeutics
MLYS
$2.39B
$43.1M 24.38%
1,591,917
AGMB
4
AgomAb Therapeutics NV
AGMB
$593M
$16.1M 9.12%
+1,538,702
New +$21.8M
IVA
5
Inventiva
IVA
$1.09B
$10.1M 5.7%
1,818,181
ABVX
6
Abivax
ABVX
$11.9B
$8.7M 4.92%
78,125
NYXH
7
Nyxoah
NYXH
$157M
$1.52M 0.86%
+522,057
New +$2.2M

Similar funds

Andera Partners's Q1 2026 Portfolio in Review

As of Q1 2026, Andera Partners held 7 positions worth $177M, up 0.17% from $177M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Andera Partners deployed $27.7M of net new capital in Q1 2026, opening 2 new positions and adding to 1 existing holding. Its largest new stake was AgomAb Therapeutics NV: 1,538,702 shares worth $16.1M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Andera Partners's largest Q1 2026 buy was AgomAb Therapeutics NV: 1,538,702 shares worth $16.1M.
  • Andera Partners added most to Kestra Medical Technologies in Q1 2026, an estimated $3.66M increase.
  • Andera Partners's ten largest holdings make up 100% of its $177M portfolio in Q1 2026.
  • Andera Partners opened 2 new positions and closed 0 in Q1 2026.
  • Andera Partners's portfolio value rose 0.17% quarter-over-quarter to $177M.

Based on Andera Partners's 13F filing for Q1 2026, filed 11 May 2026.